Filing Details

Accession Number:
0001179110-15-003817
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-02 17:41:15
Reporting Period:
2015-02-26
Filing Date:
2015-03-02
Accepted Time:
2015-03-02 17:41:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1274057 Hospira Inc HSP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1574982 R Matthew Stober C/O Hospira, Inc.
275 North Field Drive
Lake Forest IL 60045
Svp, Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-26 11,111 $42.70 98,911 No 4 M Direct
Common Stock Disposition 2015-02-26 11,111 $87.46 87,800 No 4 S Direct
Common Stock Acquisiton 2015-02-27 14,227 $28.95 102,027 No 4 M Direct
Common Stock Disposition 2015-02-27 14,227 $87.48 87,800 No 4 S Direct
Common Stock Disposition 2015-02-27 1,449 $87.49 86,351 No 4 F Direct
Common Stock Disposition 2015-02-27 2,254 $87.54 84,097 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 F Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2015-02-26 11,111 $0.00 11,111 $42.70
Common Stock Stock Option (Right to Buy) Acquisiton 2015-02-27 14,227 $0.00 14,227 $28.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
33,333 2015-02-26 2021-02-25 No 4 M Direct
28,457 2015-02-27 2020-02-26 No 4 M Direct
Footnotes
  1. Payment of tax liability by withholding securities incident to the vesting of the restricted stock units (granted February 27, 2013).
  2. Exercise of derivative security exempted pursuant to Rule 16b-3.
  3. The stock options vest in three equal annual installments on February 26, 2015, 2016 and 2017. The exercise price of $42.70 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, which expire on February 25, 2021.
  4. The stock options vest in three equal annual installments on February 27, 2014, 2015 and 2016. The exercise price of $28.950 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, which expire on February 26, 2020.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.47 to $87.48, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.